Investigational Site Number :6430002

Saint Petersburg 197758

0 studies enrolling now · 10 studies all time

What they study most

Asthma, Breast Cancer, Breast Cancer Metastatic, Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Chronic Rhinosinusitis Without Nasal Polyps, Chronic Sinusitis, Neurodermatitis, Pancreatic Carcinoma Metastatic, Relapsing Multiple Sclerosis, Respiratory Disorder, Sinus Disorder, Sinusitis

Studies at this site

• Dupilumab in CRSsNP — Completed
• Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion) — Completed
• Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors — Stopped early
• Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer — Stopped early
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME) — Completed
• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus — Completed
• A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus — Completed
• Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps — Completed
• A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps — Completed